nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—ALOX5—hematologic cancer	0.214	0.67	CbGaD
Sulfasalazine—ABCG2—hematologic cancer	0.106	0.33	CbGaD
Sulfasalazine—PLA2G1B—Betamethasone—hematologic cancer	0.0703	0.146	CbGbCtD
Sulfasalazine—PLA2G1B—Dexamethasone—hematologic cancer	0.0409	0.0849	CbGbCtD
Sulfasalazine—SLC46A1—Methotrexate—hematologic cancer	0.0328	0.0682	CbGbCtD
Sulfasalazine—PTGS2—Lenalidomide—hematologic cancer	0.0229	0.0476	CbGbCtD
Sulfasalazine—ABCG2—Clofarabine—hematologic cancer	0.021	0.0436	CbGbCtD
Sulfasalazine—ABCC2—Daunorubicin—hematologic cancer	0.0136	0.0283	CbGbCtD
Sulfasalazine—ABCG2—Daunorubicin—hematologic cancer	0.0123	0.0256	CbGbCtD
Sulfasalazine—PTGS2—Thalidomide—hematologic cancer	0.0122	0.0254	CbGbCtD
Sulfasalazine—PTGS1—Bortezomib—hematologic cancer	0.0119	0.0247	CbGbCtD
Sulfasalazine—ABCG2—Teniposide—hematologic cancer	0.0107	0.0222	CbGbCtD
Sulfasalazine—PTGS1—Thalidomide—hematologic cancer	0.0103	0.0215	CbGbCtD
Sulfasalazine—ABCG2—Cladribine—hematologic cancer	0.0102	0.0213	CbGbCtD
Sulfasalazine—ABCG2—Imatinib—hematologic cancer	0.00943	0.0196	CbGbCtD
Sulfasalazine—PTGS1—Ifosfamide—hematologic cancer	0.00911	0.0189	CbGbCtD
Sulfasalazine—PTGS1—Imatinib—hematologic cancer	0.0087	0.0181	CbGbCtD
Sulfasalazine—ABCG2—Nilotinib—hematologic cancer	0.00857	0.0178	CbGbCtD
Sulfasalazine—PTGS2—Triamcinolone—hematologic cancer	0.00849	0.0176	CbGbCtD
Sulfasalazine—ABCG2—Dasatinib—hematologic cancer	0.00757	0.0157	CbGbCtD
Sulfasalazine—ABCG2—Mitoxantrone—hematologic cancer	0.00748	0.0155	CbGbCtD
Sulfasalazine—SLCO1B1—Irinotecan—hematologic cancer	0.00741	0.0154	CbGbCtD
Sulfasalazine—PTGS2—Betamethasone—hematologic cancer	0.00728	0.0151	CbGbCtD
Sulfasalazine—CYP3A5—Daunorubicin—hematologic cancer	0.00682	0.0142	CbGbCtD
Sulfasalazine—ABCC2—Irinotecan—hematologic cancer	0.00651	0.0135	CbGbCtD
Sulfasalazine—CYP3A5—Thalidomide—hematologic cancer	0.00621	0.0129	CbGbCtD
Sulfasalazine—CYP3A5—Teniposide—hematologic cancer	0.00592	0.0123	CbGbCtD
Sulfasalazine—ABCG2—Irinotecan—hematologic cancer	0.00589	0.0122	CbGbCtD
Sulfasalazine—ABCC2—Vinblastine—hematologic cancer	0.00579	0.012	CbGbCtD
Sulfasalazine—ABCC2—Vincristine—hematologic cancer	0.00569	0.0118	CbGbCtD
Sulfasalazine—CYP3A5—Ifosfamide—hematologic cancer	0.00547	0.0114	CbGbCtD
Sulfasalazine—ABCC2—Cisplatin—hematologic cancer	0.00531	0.011	CbGbCtD
Sulfasalazine—PTGS2—Cisplatin—hematologic cancer	0.00525	0.0109	CbGbCtD
Sulfasalazine—CYP3A5—Imatinib—hematologic cancer	0.00522	0.0108	CbGbCtD
Sulfasalazine—ABCC2—Etoposide—hematologic cancer	0.00522	0.0108	CbGbCtD
Sulfasalazine—PTGS2—Etoposide—hematologic cancer	0.00515	0.0107	CbGbCtD
Sulfasalazine—ABCG2—Vincristine—hematologic cancer	0.00515	0.0107	CbGbCtD
Sulfasalazine—ABCG2—Cisplatin—hematologic cancer	0.0048	0.00997	CbGbCtD
Sulfasalazine—ABCG2—Etoposide—hematologic cancer	0.00472	0.00979	CbGbCtD
Sulfasalazine—PTGS1—Etoposide—hematologic cancer	0.00435	0.00904	CbGbCtD
Sulfasalazine—ABCC2—Dexamethasone—hematologic cancer	0.00429	0.00891	CbGbCtD
Sulfasalazine—PTGS2—Dexamethasone—hematologic cancer	0.00424	0.0088	CbGbCtD
Sulfasalazine—CYP3A5—Dasatinib—hematologic cancer	0.00419	0.00871	CbGbCtD
Sulfasalazine—SLCO1B1—Methotrexate—hematologic cancer	0.00392	0.00814	CbGbCtD
Sulfasalazine—ABCG2—Dexamethasone—hematologic cancer	0.00388	0.00805	CbGbCtD
Sulfasalazine—ABCC2—Doxorubicin—hematologic cancer	0.00356	0.00739	CbGbCtD
Sulfasalazine—ABCC2—Methotrexate—hematologic cancer	0.00345	0.00716	CbGbCtD
Sulfasalazine—CYP3A5—Irinotecan—hematologic cancer	0.00326	0.00677	CbGbCtD
Sulfasalazine—PTGS2—ovarian follicle—hematologic cancer	0.00324	0.0584	CbGeAlD
Sulfasalazine—ABCG2—Doxorubicin—hematologic cancer	0.00322	0.00668	CbGbCtD
Sulfasalazine—ABCG2—Methotrexate—hematologic cancer	0.00312	0.00647	CbGbCtD
Sulfasalazine—CYP3A5—Vincristine—hematologic cancer	0.00285	0.00592	CbGbCtD
Sulfasalazine—CYP3A5—Etoposide—hematologic cancer	0.00261	0.00543	CbGbCtD
Sulfasalazine—ACAT1—hematopoietic system—hematologic cancer	0.00243	0.0437	CbGeAlD
Sulfasalazine—CYP3A5—Dexamethasone—hematologic cancer	0.00215	0.00446	CbGbCtD
Sulfasalazine—TBXAS1—hematopoietic system—hematologic cancer	0.00203	0.0366	CbGeAlD
Sulfasalazine—ACAT1—gonad—hematologic cancer	0.00185	0.0333	CbGeAlD
Sulfasalazine—SLC46A1—hematopoietic system—hematologic cancer	0.00181	0.0326	CbGeAlD
Sulfasalazine—CHUK—hematopoietic system—hematologic cancer	0.00181	0.0326	CbGeAlD
Sulfasalazine—PLA2G1B—hematopoietic system—hematologic cancer	0.0017	0.0306	CbGeAlD
Sulfasalazine—ACAT1—bone marrow—hematologic cancer	0.00156	0.028	CbGeAlD
Sulfasalazine—ACAT1—lung—hematologic cancer	0.00141	0.0254	CbGeAlD
Sulfasalazine—TBXAS1—blood—hematologic cancer	0.00135	0.0242	CbGeAlD
Sulfasalazine—ACAT1—testis—hematologic cancer	0.00133	0.024	CbGeAlD
Sulfasalazine—TBXAS1—bone marrow—hematologic cancer	0.0013	0.0234	CbGeAlD
Sulfasalazine—IKBKB—hematopoietic system—hematologic cancer	0.00123	0.0222	CbGeAlD
Sulfasalazine—CHUK—blood—hematologic cancer	0.0012	0.0216	CbGeAlD
Sulfasalazine—TBXAS1—lung—hematologic cancer	0.00118	0.0212	CbGeAlD
Sulfasalazine—PLA2G1B—blood—hematologic cancer	0.00113	0.0203	CbGeAlD
Sulfasalazine—TBXAS1—testis—hematologic cancer	0.00111	0.02	CbGeAlD
Sulfasalazine—CHUK—lung—hematologic cancer	0.00105	0.0189	CbGeAlD
Sulfasalazine—ALOX5—hematopoietic system—hematologic cancer	0.00102	0.0184	CbGeAlD
Sulfasalazine—SLC46A1—testis—hematologic cancer	0.000993	0.0179	CbGeAlD
Sulfasalazine—CHUK—testis—hematologic cancer	0.000993	0.0179	CbGeAlD
Sulfasalazine—PLA2G1B—lung—hematologic cancer	0.000989	0.0178	CbGeAlD
Sulfasalazine—ACAT1—lymph node—hematologic cancer	0.000966	0.0174	CbGeAlD
Sulfasalazine—IKBKB—gonad—hematologic cancer	0.000936	0.0168	CbGeAlD
Sulfasalazine—PLA2G1B—testis—hematologic cancer	0.000933	0.0168	CbGeAlD
Sulfasalazine—SLCO1B1—hematopoietic system—hematologic cancer	0.000888	0.016	CbGeAlD
Sulfasalazine—SLC7A11—lung—hematologic cancer	0.000866	0.0156	CbGeAlD
Sulfasalazine—SLC7A11—testis—hematologic cancer	0.000818	0.0147	CbGeAlD
Sulfasalazine—IKBKB—blood—hematologic cancer	0.000816	0.0147	CbGeAlD
Sulfasalazine—TBXAS1—lymph node—hematologic cancer	0.000807	0.0145	CbGeAlD
Sulfasalazine—Olsalazine—IFNG—hematologic cancer	0.000792	0.29	CrCbGaD
Sulfasalazine—Balsalazide—ALOX5—hematologic cancer	0.000767	0.281	CrCbGaD
Sulfasalazine—PPARG—hematopoietic system—hematologic cancer	0.000766	0.0138	CbGeAlD
Sulfasalazine—SLC46A1—lymph node—hematologic cancer	0.00072	0.0129	CbGeAlD
Sulfasalazine—CHUK—lymph node—hematologic cancer	0.00072	0.0129	CbGeAlD
Sulfasalazine—IKBKB—lung—hematologic cancer	0.000715	0.0129	CbGeAlD
Sulfasalazine—ALOX5—blood—hematologic cancer	0.000676	0.0122	CbGeAlD
Sulfasalazine—IKBKB—testis—hematologic cancer	0.000675	0.0121	CbGeAlD
Sulfasalazine—ALOX5—bone marrow—hematologic cancer	0.000654	0.0118	CbGeAlD
Sulfasalazine—Olsalazine—ALOX5—hematologic cancer	0.000652	0.239	CrCbGaD
Sulfasalazine—ALOX5—lung—hematologic cancer	0.000593	0.0107	CbGeAlD
Sulfasalazine—SLCO1B1—blood—hematologic cancer	0.000589	0.0106	CbGeAlD
Sulfasalazine—ALOX5—testis—hematologic cancer	0.000559	0.0101	CbGeAlD
Sulfasalazine—PPARG—Ponatinib—Nilotinib—hematologic cancer	0.000532	0.2	CbGdCrCtD
Sulfasalazine—PPARG—blood—hematologic cancer	0.000508	0.00913	CbGeAlD
Sulfasalazine—PPARG—bone marrow—hematologic cancer	0.000491	0.00884	CbGeAlD
Sulfasalazine—IKBKB—lymph node—hematologic cancer	0.000489	0.0088	CbGeAlD
Sulfasalazine—CYP3A5—hematopoietic system—hematologic cancer	0.000456	0.0082	CbGeAlD
Sulfasalazine—ABCC2—blood—hematologic cancer	0.000446	0.00803	CbGeAlD
Sulfasalazine—PPARG—lung—hematologic cancer	0.000445	0.00801	CbGeAlD
Sulfasalazine—PPARG—testis—hematologic cancer	0.00042	0.00755	CbGeAlD
Sulfasalazine—PTGS1—hematopoietic system—hematologic cancer	0.00041	0.00737	CbGeAlD
Sulfasalazine—ALOX5—lymph node—hematologic cancer	0.000405	0.00729	CbGeAlD
Sulfasalazine—PPARG—Ponatinib—Imatinib—hematologic cancer	0.000403	0.151	CbGdCrCtD
Sulfasalazine—PTGS2—hematopoietic system—hematologic cancer	0.000392	0.00704	CbGeAlD
Sulfasalazine—PPARG—Topotecan—Irinotecan—hematologic cancer	0.000382	0.143	CbGdCrCtD
Sulfasalazine—PPARG—Etoposide—Teniposide—hematologic cancer	0.00038	0.142	CbGdCrCtD
Sulfasalazine—ABCC2—testis—hematologic cancer	0.000369	0.00664	CbGeAlD
Sulfasalazine—ABCG2—blood—hematologic cancer	0.000325	0.00585	CbGeAlD
Sulfasalazine—ABCG2—bone marrow—hematologic cancer	0.000315	0.00566	CbGeAlD
Sulfasalazine—PPARG—lymph node—hematologic cancer	0.000304	0.00548	CbGeAlD
Sulfasalazine—CYP3A5—blood—hematologic cancer	0.000302	0.00543	CbGeAlD
Sulfasalazine—ABCG2—lung—hematologic cancer	0.000285	0.00513	CbGeAlD
Sulfasalazine—Vismodegib—ABCG2—hematologic cancer	0.000282	0.103	CrCbGaD
Sulfasalazine—PTGS1—blood—hematologic cancer	0.000271	0.00488	CbGeAlD
Sulfasalazine—ABCG2—testis—hematologic cancer	0.000269	0.00484	CbGeAlD
Sulfasalazine—ABCC2—lymph node—hematologic cancer	0.000268	0.00481	CbGeAlD
Sulfasalazine—CYP3A5—lung—hematologic cancer	0.000265	0.00476	CbGeAlD
Sulfasalazine—PTGS2—blood—hematologic cancer	0.000259	0.00467	CbGeAlD
Sulfasalazine—PTGS2—bone marrow—hematologic cancer	0.000251	0.00452	CbGeAlD
Sulfasalazine—PTGS1—lung—hematologic cancer	0.000238	0.00428	CbGeAlD
Sulfasalazine—PTGS2—lung—hematologic cancer	0.000227	0.00409	CbGeAlD
Sulfasalazine—PTGS1—testis—hematologic cancer	0.000225	0.00404	CbGeAlD
Sulfasalazine—ABCG2—lymph node—hematologic cancer	0.000195	0.00351	CbGeAlD
Sulfasalazine—PPARG—Teniposide—Etoposide—hematologic cancer	0.000172	0.0646	CbGdCrCtD
Sulfasalazine—PTGS1—lymph node—hematologic cancer	0.000163	0.00293	CbGeAlD
Sulfasalazine—PTGS2—lymph node—hematologic cancer	0.000156	0.0028	CbGeAlD
Sulfasalazine—Vismodegib—ALB—hematologic cancer	0.000123	0.045	CrCbGaD
Sulfasalazine—Vismodegib—ABCB1—hematologic cancer	0.000117	0.043	CrCbGaD
Sulfasalazine—PTGS2—Fluocinonide—Dexamethasone—hematologic cancer	7.3e-05	0.0274	CbGdCrCtD
Sulfasalazine—PTGS2—Fluocinonide—Betamethasone—hematologic cancer	7.3e-05	0.0274	CbGdCrCtD
Sulfasalazine—PTGS2—Fluocinonide—Triamcinolone—hematologic cancer	7.13e-05	0.0267	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Betamethasone—hematologic cancer	5.9e-05	0.0221	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Dexamethasone—hematologic cancer	5.9e-05	0.0221	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Triamcinolone—hematologic cancer	5.76e-05	0.0216	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Triamcinolone—hematologic cancer	5.76e-05	0.0216	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Prednisone—hematologic cancer	5.47e-05	0.0205	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Prednisone—hematologic cancer	5.47e-05	0.0205	CbGdCrCtD
Sulfasalazine—SLC7A11—Dexamethasone—Prednisolone—hematologic cancer	5.34e-05	0.02	CbGdCrCtD
Sulfasalazine—SLC7A11—Betamethasone—Prednisolone—hematologic cancer	5.34e-05	0.02	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Dexamethasone—hematologic cancer	4.4e-05	0.0165	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Betamethasone—hematologic cancer	4.4e-05	0.0165	CbGdCrCtD
Sulfasalazine—PTGS2—Fluticasone Propionate—Triamcinolone—hematologic cancer	4.3e-05	0.0161	CbGdCrCtD
Sulfasalazine—CHUK—Signaling Pathways—NFKBIA—hematologic cancer	1.62e-06	1.18e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CDKN1B—hematologic cancer	1.61e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TSC2—hematologic cancer	1.61e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CDKN1A—hematologic cancer	1.61e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PTEN—hematologic cancer	1.61e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NOTCH1—hematologic cancer	1.6e-06	1.17e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—AKT1—hematologic cancer	1.59e-06	1.16e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CDKN1B—hematologic cancer	1.58e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MTHFR—hematologic cancer	1.58e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.57e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HLA-A—hematologic cancer	1.57e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TERT—hematologic cancer	1.57e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CG—hematologic cancer	1.57e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MAPK8—hematologic cancer	1.57e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CD80—hematologic cancer	1.57e-06	1.15e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CG—hematologic cancer	1.57e-06	1.14e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KIT—hematologic cancer	1.57e-06	1.14e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—HRAS—hematologic cancer	1.57e-06	1.14e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—IL6—hematologic cancer	1.56e-06	1.14e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL1B—hematologic cancer	1.55e-06	1.13e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FGFR3—hematologic cancer	1.55e-06	1.13e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL2—hematologic cancer	1.55e-06	1.13e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ABCB1—hematologic cancer	1.54e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTPN11—hematologic cancer	1.54e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PDGFB—hematologic cancer	1.54e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAPK14—hematologic cancer	1.53e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—EP300—hematologic cancer	1.53e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PIK3CB—hematologic cancer	1.53e-06	1.12e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTP1—hematologic cancer	1.53e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—AKT1—hematologic cancer	1.53e-06	1.11e-05	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PIK3CA—hematologic cancer	1.51e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—JUN—hematologic cancer	1.51e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ESR1—hematologic cancer	1.5e-06	1.1e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TSC2—hematologic cancer	1.5e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—NCOR1—hematologic cancer	1.5e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTM1—hematologic cancer	1.5e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CREB1—hematologic cancer	1.49e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—SRC—hematologic cancer	1.49e-06	1.09e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CDKN1A—hematologic cancer	1.49e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FN1—hematologic cancer	1.49e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTEN—hematologic cancer	1.48e-06	1.08e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—BRAF—hematologic cancer	1.47e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—BAD—hematologic cancer	1.47e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NFKBIA—hematologic cancer	1.47e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.47e-06	1.07e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCL2—hematologic cancer	1.46e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CDKN1A—hematologic cancer	1.46e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CREBBP—hematologic cancer	1.46e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CG—hematologic cancer	1.46e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PTEN—hematologic cancer	1.46e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6R—hematologic cancer	1.46e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NOTCH1—hematologic cancer	1.45e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CREBBP—hematologic cancer	1.45e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MAPK3—hematologic cancer	1.45e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ABCB1—hematologic cancer	1.45e-06	1.06e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FGFR3—hematologic cancer	1.44e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—AKT1—hematologic cancer	1.44e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—STAT3—hematologic cancer	1.44e-06	1.05e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—NRAS—hematologic cancer	1.43e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MAPK8—hematologic cancer	1.42e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CD80—hematologic cancer	1.42e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KIT—hematologic cancer	1.42e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CG—hematologic cancer	1.42e-06	1.04e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—EP300—hematologic cancer	1.41e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—MYC—hematologic cancer	1.41e-06	1.03e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTM1—hematologic cancer	1.41e-06	1.02e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—NCOR1—hematologic cancer	1.41e-06	1.02e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CG—hematologic cancer	1.4e-06	1.02e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTPN11—hematologic cancer	1.4e-06	1.02e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—EP300—hematologic cancer	1.39e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAP2K1—hematologic cancer	1.39e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—AKT1—hematologic cancer	1.38e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CD—hematologic cancer	1.38e-06	1.01e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CD—hematologic cancer	1.38e-06	1e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—SRC—hematologic cancer	1.37e-06	1e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—MAPK3—hematologic cancer	1.37e-06	1e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—BAD—hematologic cancer	1.37e-06	9.98e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—ALB—hematologic cancer	1.36e-06	9.95e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NOTCH1—hematologic cancer	1.36e-06	9.89e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CREB1—hematologic cancer	1.35e-06	9.87e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—SRC—hematologic cancer	1.35e-06	9.84e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CREBBP—hematologic cancer	1.35e-06	9.84e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—BRAF—hematologic cancer	1.34e-06	9.74e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD80—hematologic cancer	1.33e-06	9.69e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KIT—hematologic cancer	1.33e-06	9.67e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—STAT3—hematologic cancer	1.33e-06	9.67e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCL2—hematologic cancer	1.32e-06	9.65e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—NRAS—hematologic cancer	1.32e-06	9.64e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTEN—hematologic cancer	1.32e-06	9.64e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—MTHFR—hematologic cancer	1.32e-06	9.64e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6R—hematologic cancer	1.32e-06	9.62e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—FGF2—hematologic cancer	1.32e-06	9.62e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CREBBP—hematologic cancer	1.32e-06	9.61e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3R1—hematologic cancer	1.31e-06	9.52e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PTPN11—hematologic cancer	1.3e-06	9.5e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—STAT3—hematologic cancer	1.3e-06	9.49e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3R1—hematologic cancer	1.3e-06	9.49e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—NRAS—hematologic cancer	1.3e-06	9.47e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CREBBP—hematologic cancer	1.3e-06	9.46e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CD—hematologic cancer	1.28e-06	9.33e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MAPK3—hematologic cancer	1.27e-06	9.23e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—JAK2—hematologic cancer	1.26e-06	9.22e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—ALB—hematologic cancer	1.26e-06	9.21e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CREB1—hematologic cancer	1.26e-06	9.2e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—EP300—hematologic cancer	1.26e-06	9.19e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAP2K1—hematologic cancer	1.26e-06	9.17e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CD—hematologic cancer	1.25e-06	9.11e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—BRAF—hematologic cancer	1.25e-06	9.09e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—MAPK3—hematologic cancer	1.24e-06	9.07e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—MTHFR—hematologic cancer	1.24e-06	9.05e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MDM2—hematologic cancer	1.23e-06	9e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—KRAS—hematologic cancer	1.23e-06	8.99e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—MYC—hematologic cancer	1.23e-06	8.98e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6R—hematologic cancer	1.23e-06	8.98e-06	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—AKT1—hematologic cancer	1.23e-06	8.98e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CD—hematologic cancer	1.23e-06	8.97e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CREBBP—hematologic cancer	1.23e-06	8.96e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—TGFB1—hematologic cancer	1.23e-06	8.96e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—ALB—hematologic cancer	1.21e-06	8.85e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3R1—hematologic cancer	1.21e-06	8.81e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CB—hematologic cancer	1.21e-06	8.79e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MTOR—hematologic cancer	1.2e-06	8.76e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CB—hematologic cancer	1.2e-06	8.76e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—FGF2—hematologic cancer	1.2e-06	8.72e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3R1—hematologic cancer	1.18e-06	8.6e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAP2K1—hematologic cancer	1.17e-06	8.56e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CD—hematologic cancer	1.17e-06	8.5e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	1.16e-06	8.49e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3R1—hematologic cancer	1.16e-06	8.47e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—JAK2—hematologic cancer	1.15e-06	8.36e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—KRAS—hematologic cancer	1.14e-06	8.3e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—PIK3CA—hematologic cancer	1.13e-06	8.26e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CDKN1B—hematologic cancer	1.13e-06	8.22e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MDM2—hematologic cancer	1.12e-06	8.16e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—KRAS—hematologic cancer	1.12e-06	8.15e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—FGF2—hematologic cancer	1.12e-06	8.14e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CB—hematologic cancer	1.12e-06	8.13e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CG—hematologic cancer	1.11e-06	8.1e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CASP3—hematologic cancer	1.1e-06	8.06e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL2—hematologic cancer	1.1e-06	8.04e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3R1—hematologic cancer	1.1e-06	8.03e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MTOR—hematologic cancer	1.09e-06	7.94e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CB—hematologic cancer	1.09e-06	7.94e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CCND1—hematologic cancer	1.08e-06	7.84e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—JUN—hematologic cancer	1.07e-06	7.82e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CB—hematologic cancer	1.07e-06	7.82e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—JAK2—hematologic cancer	1.07e-06	7.8e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—HRAS—hematologic cancer	1.05e-06	7.64e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PIK3CA—hematologic cancer	1.05e-06	7.62e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MDM2—hematologic cancer	1.04e-06	7.61e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CG—hematologic cancer	1.04e-06	7.61e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTEN—hematologic cancer	1.04e-06	7.59e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CDKN1A—hematologic cancer	1.04e-06	7.58e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PTEN—hematologic cancer	1.04e-06	7.57e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CREBBP—hematologic cancer	1.03e-06	7.51e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—PIK3CA—hematologic cancer	1.03e-06	7.49e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CDKN1B—hematologic cancer	1.02e-06	7.45e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MTOR—hematologic cancer	1.02e-06	7.41e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CB—hematologic cancer	1.02e-06	7.41e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAPK8—hematologic cancer	1.02e-06	7.4e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CD4—hematologic cancer	1.01e-06	7.39e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—IL6—hematologic cancer	1e-06	7.31e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CASP3—hematologic cancer	1e-06	7.3e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL2—hematologic cancer	1e-06	7.29e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—EP300—hematologic cancer	9.93e-07	7.24e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—EP300—hematologic cancer	9.9e-07	7.22e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—AKT1—hematologic cancer	9.8e-07	7.15e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CD—hematologic cancer	9.76e-07	7.12e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CCND1—hematologic cancer	9.75e-07	7.11e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—JUN—hematologic cancer	9.73e-07	7.09e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—HRAS—hematologic cancer	9.68e-07	7.05e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CREBBP—hematologic cancer	9.67e-07	7.05e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTEN—hematologic cancer	9.64e-07	7.03e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—ALB—hematologic cancer	9.64e-07	7.03e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SRC—hematologic cancer	9.63e-07	7.02e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDKN1B—hematologic cancer	9.54e-07	6.95e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—HRAS—hematologic cancer	9.5e-07	6.93e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CDKN1A—hematologic cancer	9.43e-07	6.88e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PTEN—hematologic cancer	9.41e-07	6.86e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFA—hematologic cancer	9.38e-07	6.84e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PIK3CA—hematologic cancer	9.33e-07	6.8e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—STAT3—hematologic cancer	9.28e-07	6.77e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTEN—hematologic cancer	9.26e-07	6.75e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—NRAS—hematologic cancer	9.26e-07	6.75e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—IL6—hematologic cancer	9.26e-07	6.75e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—AKT1—hematologic cancer	9.25e-07	6.75e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3R1—hematologic cancer	9.22e-07	6.72e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAPK8—hematologic cancer	9.21e-07	6.71e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—EP300—hematologic cancer	9.2e-07	6.7e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CD—hematologic cancer	9.17e-07	6.69e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—IL6—hematologic cancer	9.1e-07	6.63e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—ALB—hematologic cancer	9.05e-07	6.6e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—EP300—hematologic cancer	8.98e-07	6.54e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MAPK3—hematologic cancer	8.87e-07	6.47e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—EP300—hematologic cancer	8.83e-07	6.44e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CDKN1A—hematologic cancer	8.8e-07	6.42e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PTEN—hematologic cancer	8.78e-07	6.4e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SRC—hematologic cancer	8.73e-07	6.36e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3R1—hematologic cancer	8.66e-07	6.31e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MYC—hematologic cancer	8.63e-07	6.29e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TGFB1—hematologic cancer	8.61e-07	6.27e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—AKT1—hematologic cancer	8.54e-07	6.23e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CB—hematologic cancer	8.51e-07	6.2e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFA—hematologic cancer	8.5e-07	6.2e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—STAT3—hematologic cancer	8.42e-07	6.14e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—NRAS—hematologic cancer	8.4e-07	6.12e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—AKT1—hematologic cancer	8.39e-07	6.12e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—EP300—hematologic cancer	8.37e-07	6.1e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—SRC—hematologic cancer	8.14e-07	5.94e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MAPK3—hematologic cancer	8.04e-07	5.86e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CB—hematologic cancer	7.99e-07	5.83e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—KRAS—hematologic cancer	7.97e-07	5.81e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—STAT3—hematologic cancer	7.85e-07	5.73e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—NRAS—hematologic cancer	7.83e-07	5.71e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MYC—hematologic cancer	7.82e-07	5.7e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TGFB1—hematologic cancer	7.8e-07	5.69e-06	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—AKT1—hematologic cancer	7.62e-07	5.56e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MAPK3—hematologic cancer	7.5e-07	5.47e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PTEN—hematologic cancer	7.35e-07	5.36e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PIK3CA—hematologic cancer	7.35e-07	5.36e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PIK3CA—hematologic cancer	7.32e-07	5.34e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—MYC—hematologic cancer	7.3e-07	5.32e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TGFB1—hematologic cancer	7.28e-07	5.31e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—KRAS—hematologic cancer	7.23e-07	5.27e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—hematologic cancer	7.08e-07	5.16e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—EP300—hematologic cancer	7.01e-07	5.11e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTEN—hematologic cancer	6.91e-07	5.04e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PIK3CA—hematologic cancer	6.8e-07	4.96e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—HRAS—hematologic cancer	6.78e-07	4.94e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—KRAS—hematologic cancer	6.74e-07	4.92e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PIK3CA—hematologic cancer	6.64e-07	4.84e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—EP300—hematologic cancer	6.59e-07	4.8e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PIK3CA—hematologic cancer	6.54e-07	4.76e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IL6—hematologic cancer	6.49e-07	4.73e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—hematologic cancer	6.42e-07	4.68e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PIK3CA—hematologic cancer	6.19e-07	4.52e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—HRAS—hematologic cancer	6.14e-07	4.48e-06	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—AKT1—hematologic cancer	6e-07	4.37e-06	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—AKT1—hematologic cancer	5.98e-07	4.36e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IL6—hematologic cancer	5.88e-07	4.29e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—HRAS—hematologic cancer	5.73e-07	4.18e-06	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—AKT1—hematologic cancer	5.56e-07	4.05e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—IL6—hematologic cancer	5.49e-07	4e-06	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—AKT1—hematologic cancer	5.42e-07	3.95e-06	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—AKT1—hematologic cancer	5.34e-07	3.89e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PIK3CA—hematologic cancer	5.19e-07	3.78e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—AKT1—hematologic cancer	5.06e-07	3.69e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PIK3CA—hematologic cancer	4.87e-07	3.55e-06	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—AKT1—hematologic cancer	4.24e-07	3.09e-06	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—AKT1—hematologic cancer	3.98e-07	2.9e-06	CbGpPWpGaD
